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INTRODUCTION: Metastatic tumors account for 1.4–2.5% of thyroid malignancies. About 25–30% of
patients with clear cell renal carcinoma (CCRC) have distant metastasis at the time of diagnosis, being
the thyroid gland a rare localization [5%].
PRESENTATION OF THE CASE: A 62-year woman who underwent a cervical ultrasonography and a PAAF
biopsy reporting atypical follicular proliferation with a few intranuclear vacuoles “suggestive” of thy-
roid papillary cancer in the context of a multinodular goiter was reported. A total thyroidectomy was
performed and the histology of a clear cell renal carcinoma (CCRC) was described in four nodules of the
thyroid gland. A CT scan was performed and a renal giant right tumor was found. The patient underwent
an eventful radical right nephrectomy and the diagnosis of CCRC was conﬁrmed.
DISCUSSION: Thyroid metastasis (TM) from CCRC are usually apparent in a metachronic context during
the follow-up of a treated primary (even many years after) but may sometimes be present at the same
time than the primary renal tumor. Our case is exceptional because the TM was the ﬁrst evidence of the
CCRC, which was subsequently diagnosed and treated.
CONCLUSION: The possibility of ﬁnding of an incidental metastatic tumor in the thyroid gland from a
previous unknown and non-diganosed primary (as CCRC in our case was) is rare and account only for less
than 1% of malignancies. Nonetheless, the thyroid gland is a frequent site of metastasis and the presence
of “de novo” thyroid nodules in oncologic patients must be always considered and studied.
© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Clear cell renal carcinoma (CCRC) is a tumor with a highly
metastatic capacity due to its rich vascularization and the pres-
ence of internal arterio-venous shunts. Up to 30% of all cases have
extended disease at the time of diagnosis and recurrences have
been reported over 20 years after resection of the primary tumor
[1].
Thyroid metastasis (TM) from extrathyroid cancer accounts for
1.4–2.5% of malignant thyroid tumors, usually in relation with
renal, bronchial and digestive tumors and melanoma [2,3]. We
report the case of a patient with a diagnosis of CCRC which was
made incidentally during thehistological study of a specimen taken
from a total thyroidectomy. We discuss the epidemiological, clini-
cal and diagnostic implications, as well as the therapeutic options
for TM in general and those associated with CCRC in particular.
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2. Presentation of case
An otherwise healthy 62-year woman was studied for a goi-
ter with no local symptoms of thyroid dysfunction. Physical exam
and ultrasonography (US) showed a palpable multinodular goiter
with a 22mm dominant nodule poorly deﬁned in the right thy-
roid lobe and no palpable lymph nodes. Fine needle aspiration
biopsy (FNAB) was reported as atypical follicular proliferation with
a few intranuclear vacuoles suggestive of thyroid papillary cancer
(Bethesda 5). A total thyroidectomy with a prophylactic central
compartment dissection was performed with a 3 days unevent-
ful postoperative course. Histological study informed the presence
in four adenomatoyd nodules of groups of large cells arranged in
nests and cords with optically clear cytoplasm and enlarged nuclei
displaying coarse chromatin, ﬁndings clearly suggestive of renal
origin, with focal inﬁltration of the thyroid capsule (Fig. 1). No pri-
mary (neither papillary nor follicular benign or malignant) thyroid
neoplasm was found, resulting then the previous FNAB as a false
positive for malignancy. Immunohistochemistry proved negative
for speciﬁc thyroid transcription factor-1 (TTF-1) and thyroglobu-
lin and positive for CD10. Abdominal computerized tomography
(CT) and magnetic resonance imaging (MRI) detected the pres-
ence of a solid, hypervascular mass in the upper pole of the right
http://dx.doi.org/10.1016/j.ijscr.2015.03.003
2210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. Haematoxylin–eosin stain (×4) showing the interphase between the normal
colloidal follicular tissue and the nests of atypical cells (with abundant clear cyto-
plasm and central nucleus) separated by a bundle of sinusoidal vascular structures.
kidney measuring 12×12×10 cm with a high content of cytoplas-
mic fat and the presence of microcalciﬁcations and arterio-venous
ﬁstulas, growing into the perirenal space and displacing, though
not inﬁltrating, the right hepatic lobe, the inferior vena cava and
the ascending colon (Fig. 2A and B). Four weeks later, the patient
underwent a radical right nephrectomy (including perirenal fat,
right adrenal and lymph nodes of the renal hilum) with no postop-
erative complications. Histological study reported a conventional
CCRCwith Fuhrmannuclear grade 1 and extensive areas of necrosis
and hemorrhage, inﬁltration of the Gerota capsule and extending
into the renal vein,withno involvementof the resectionborder. The
patient received no adjuvant chemotherapy, and remains free of
disease after four years of follow-up (including a positron emission
tomographic study one month ago).
3. Discussion
Clear cell renal carcinoma accounts for 3% of all malignant
tumors in adults and it is the third most frequent urological tumor
beingmore common inmenandusually at theageof65-year. About
25–30% of patients with CCRC have distant metastasis at the time
of diagnosis. The most frequent sites of metastasis are the respira-
tory tract, skeleto–muscular system, lymph nodes, brain, liver and
skin, with solitary metastasis found in 1–4% of cases. Saitoh stud-
ied a series of 1828 patients with CCRC and found that 5.2% of the
previously asymptomatic patients had TM at autopsy [1,2].
The prevalence of TM in autopsy series of patients harboring
non-thyroid malignancies is 1.2–24%, and they are usually small,
silent and most frequently associated with renal carcinoma, breast,
liver and lung cancer, and melanoma [3]. Although kidney is the
second most vascularized organ in the body (after the suprarenal
gland) and considering that metastatic spread to the thyroid gland
is hematogenous, TM of CCRC are rare. This can be explained by: (1)
ﬁltering effect of lung passage; (2) the high intrathyroidal vascular
ﬂow, which hinders ﬁxation of tumor emboli; and (3) the high con-
centration of oxygen and iodine in the thyroid tissue, which blocks
proliferation of tumor cells [4]. Underlying thyroid disorder (ade-
noma, thyroiditis, multinodular goiter or primary tumor) may alter
the vascular ﬂow and have a role as a factor favoring the appear-
ance of metastasis in the thyroid gland because of reducing content
in oxygen and iodine. Heffes et al., in the largest series of TM from
CCRC, found pre-existing thyroid disease in 42% of the 36 cases [5].
The symptoms of TM are very unspeciﬁc and there is not usually
any repercussion on thyroid function. TM are usually detected after
Fig. 2. (A) Transverse slice on abdominal CT. (B) Lateral sagittal slice on abdominal
MRI (T1 weighted).
A heterogeneous and hypervascular mass on the right kidney, presenting arterio-
venous shunts and calciﬁcations, displacing but not inﬁltrating the liver, vena cava
and hepatic ﬂexure of the colon.
the diagnosis of the primary tumor, with a mean time to detection
of 7–10 years (range, 1–322 months) and a peak incidence during
the sixth decade of life. The presence of a long latency period is
particularly typical of CCRC and it is a factor that hinders diagnosis
even further [5].
Neither ultrasonography nor scintigraphy provide speciﬁc data,
usually visualising the presence of a cold, hypoechogenic nodule
in a euthyroid patient. Fine needle aspiration biopsy is an impor-
tant diagnostic tool that can provide a preoperative diagnosis, but
sometimes the TM are not concrete nodules but a group of cells
inside anatomically detected abnormalities in the thyroid gland.
The presence of a predominantly interstitial pattern of inﬁltration
is more compatible with the diagnosis of TM, as the pattern of pri-
mary thyroid tumors is follicular inﬁltration. The existence of large
amounts of lipidmaterial and glycogen (PASpositive), aswell as the
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absenceofmucin, anegative stain forTTF-1and thyroglobulin (both
of them positive in primary thyroid cancer) and a positivity for
CD10, all favor a diagnosis of CCRC and suggest metastasis. Medas
et al. have recently presented a review of the complex and unusual
context represented by patients with a renal cancer metastatic to a
thyroid tumor (“tumor-to-tumor” metastases), remarking how dif-
ﬁcult is to achieve thepreoperativediagnosis of a secondary thyroid
neoplasm [6].
Factors associated with a favorable prognosis of CCRC after
resection of the TM include a long time interval between tumor
resection and development of the metastasis (generally more than
10years), complete excisionof themetastatic focus, a single thyroid
lesion with no disease extended elsewhere, extensive necrosis in
the resected piece, slow tumor growth with no clinical symptoms
(casual ﬁnding on examination or in follow-up imaging studies),
and the histological characteristics of the primary tumor. Following
nephrectomy, the mean 5-year survival can reach 80% in cases of
single thyroid metastasis versus just 5% in cases of multiple metas-
tases. A longer survival has been reported for TM due to CCRC (80%
at 2 years) as opposed to TM due to other primary tumors (20% at 2
years) [5,7]. In a recent review of the literature related to this topic,
Beutner et al. found only one case of synchronous primary CCRC
and TM, being the majority of the cases metachronous late onset of
the TM. [8].
Thus, the presence of thyroid nodules in a patient with a known
history of malignant neoplasm in the kidney should orient us
toward the possibility of metastatic disease. If the FNAB shows
clear cells, a whole-body CT and PET are done to discard disease
spread to other sites. CCRC is a tumor resistant to both chemother-
apy and radiotherapy, remaining surgery the treatment of choice
because survival is longer for patients undergoing thyroidectomy
compared with those who do not. When TM are isolated, total
thyroidectomy is indicated although some authors propose unilat-
eral surgery (lobectomy and isthmectomy) in well-localized single
lesions, attributing a possible cytostatic role of the thyroid hor-
mones [9,10]. As far as we know, this is the ﬁrst case report
published of a CCRC diagnosed incidentally after a thyroidectomy
performed by a suspect of papillary carcinoma.
4. Conclusion
Thyroid nodules with FNAB informed as suspicious for malig-
nancy result occasionally in the diagnosis of a metastatic tumor
from an unnoticed primary when thyroidectomy is performed.
In these situations, CCRC is one of the most frequent metastatic
tumors to the thyroid gland.
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